Studies have shown that the potential of tocotrienol in the prevention of prostate cancer

The latest research shows that vitamin E is good for cancer Experiments show that different forms of vitamin E can prevent tumor growth in mice The August issue of the journal Nutrition and cancer showed that high doses of the tocotrienol mixture had a protective effect on tumors Mixed tocotrienols inhibited the growth of the prostate gland in mice without any toxic effects, the researchers noted There are eight forms of vitamin E: four tocopherols (α, β, γ, δ) and four tocotrienols (α, β, γ, δ)) The current study uses a hybrid, carotech tocomin brand The complex products used in the current study are the brand of carotech tocomin, which includes D - α - tocotrienol (12-14%), D - β - tocotrienol (1%), D - γ - tocotrienol (18-20%), D - δ - tocotrienol (4-6%) and D - α - Vitamin E (12-14%) In the model study, 40 mice were divided into three groups: treatment group and control group The researchers chose a genetically modified prostate cancer mouse model because it is similar to every step of human prostate cancer All the animals were fed the same food, but the treatment group also received 0.1%, 0.3% or 1% biothrenophenol, the doses were 1.7, 5.2 and 17.1mg respectively Contact feeding for 24 weeks The mice were all eight weeks old During the experiment, they were routinely measured for weight and monitored for health The study found that there was no significant change in body weight whether they were fed tocotrienol or a normal diet A small number of cancer researchers showed that after the trial, the cancer dose in the group fed the tocotrienol mixture decreased significantly compared to the control group The tests showed that 38%, 33% and 22% of the groups who received 0.1%, 0.3% and 1% mixed tocotrienols were at risk of developing cancer, respectively In addition, mixed tocotrienol can also inhibit advanced prostate cancer from developing into cancer completely It is mainly through the regulation of cell cycle and the influence of acute protein expression Their study supports the possibility of tocotrienol as a chemopreventive against prostate cancer in humans, the researchers said.